Showing results (31-40 of 75) with videos related to
Sort By:
Pageof 8
Cancer Discovery|April 29, 2025
Cancer-Associated Cachexia: Bridging Clinical Findings with Mechanistic Insights in Human StudiesKexin Koh, Rachel Scott, Elizabeth M Cespedes Feliciano, et al.Clinical Lymphoma, Myeloma & Leukemia|December 26, 2018
Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin LymphomasBruce D Cheson, Susan O'Brien, Michael S Ewer, et al.Biorxiv : the Preprint Server for Biology|June 6, 2025
Sustained Glucose Turnover Flux Distinguishes Cancer Cachexia from Nutrient LimitationYoung-Yon Kwon, Yanshan Liang, Maria Gomez-Jenkins, et al.Cancer Medicine|February 25, 2022
Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatmentDazhi Liu, Michael A Weintraub, Christine Garcia, et al.Nature Metabolism|April 17, 2026
Fructose: metabolic signal and modern hazardRichard J Johnson, Miguel A Lanaspa, Dean R Tolan, et al.Journal of Cachexia, Sarcopenia and Muscle|August 20, 2025
Reduced Muscle Loss in Patients With NSCLC Taking Fibrates: Findings From a Retrospective Observational StudyRahmi Elahjji, Tahj Blow, Rahul Grover, et al.British Journal of Cancer|May 13, 2025
Multi-node inhibition targeting mTORC1, mTORC2 and PI3Kα potently inhibits the PI3K/AKT/mTOR pathway in endometrial and breast cancer modelsPetros A Tyrakis, Domen Kampjut, Georgina F Steele, et al.Biorxiv : the Preprint Server for Biology|November 19, 2025
Hepatic ceramide synthesis links systemic inflammation to organelle dysfunction in cancerYing Liu, Ting Miao, Alice Wang, et al.Nature Nanotechnology|December 1, 2022
Selective targeting of visceral adiposity by polycation nanomedicineQianfen Wan, Baoding Huang, Tianyu Li, et al.Nature Metabolism|April 24, 2025
Hepatic gluconeogenesis and PDK3 upregulation drive cancer cachexia in flies and miceYing Liu, Ezequiel Dantas, Miriam Ferrer, et al.Pageof 8